Ann Acad Med Singap
-
Ann Acad Med Singap · Oct 2020
Impact of Telemedicine on Hospitalisation and Mortality Rates in Community-Based Haemodialysis Centres in Singapore during the COVID-19 Pandemic.
With the unprecedented challenges imposed on the modern healthcare system due to the COVID-19 pandemic, innovative solutions needed to be swiftly implemented to maintain clinical oversight on patient care. Telemedicine was introduced in Singapore in community-based haemodialysis (HD) centres to comply with the Ministry of Health's directives on movement restriction of healthcare workers and related measures to minimise the spread of SARS-CoV-2 in healthcare facilities. ⋯ Patients received appropriate care in a timely manner, with telemedicine implementation, and such measures did not lead to suboptimal healthcare outcomes. Telemedicine was a successful tool for physician oversight under movement control measures implemented during the COVID-19 pandemic and may continue to prove useful in the 'new normal' era of healthcare delivery for HD patients in community-based dialysis centres, operated by the National Kidney Foundation in Singapore.
-
Ann Acad Med Singap · Oct 2020
Adoption of Robotic Liver, Pancreatic and Biliary Surgery in Singapore: A Single Institution Experience with Its First 100 Consecutive Cases.
Presently, robotic hepatopancreatobiliary surgery (RHPBS) is increasingly adopted worldwide. This study reports our experience with the first 100 consecutive cases of RHPBS in Singapore. ⋯ Our experience with the first 100 consecutive cases of RHPBS confirms its feasibility and safety when performed by experienced laparoscopic hepatopancreatobiliary surgeons. It can be performed for even highly complicated major hepatopancreatobiliary surgery with a low open conversion rate.
-
Ann Acad Med Singap · Oct 2020
Meta AnalysisThe Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
A systematic review and meta-analysis was carried out to examine the role of hydroxychloroquine (HCQ) in the treatment of COVID-19. ⋯ The meta-analysis found that there was no clinical benefit of using either HCQ by itself or in combination with AZM for the treatment of COVID-19 patients. Hence, it may be prudent for clinicians and researchers to focus on other therapeutic options that may show greater promise in this disease.